Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 10Endometrial Neoplasms 9Vulvar Neoplasms 3Uterine Neoplasms 2Ovarian Neoplasms 2Sentinel Lymph Node Biopsy (SLNB) 1Recurrence 1Recurent Vulvar Carcinoma 1Fallopian Tube Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Cervical Adenocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Taxes 2Immunoglobulin G 2Disulfides 2Bevacizumab 2pembrolizumab 1Yoga 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Salpingo-oophorectomy 1Radiation 1Platinum 1Paclitaxel 1Congresses as Topic 1Cisplatin 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cervical Adenocarcinoma × Sentinel Lymph Node Biopsy × Gynecologic × Clear all
NCT01048853 2026-01-07

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

M.D. Anderson Cancer Center

Phase NA Terminated
137 enrolled 15 charts
Gynecologic

Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡